AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
MAXIMAL ANDROGEN BLOCKADE - FINAL ANALYSIS OF EORTC PHASE-III TRIAL-30853
Authors: DENIS LJ KEUPPENS F SMITH PH WHELAN P DEMOURA JLC NEWLING D BONO A SYLVESTER R
Citation: Lj. Denis et al., MAXIMAL ANDROGEN BLOCKADE - FINAL ANALYSIS OF EORTC PHASE-III TRIAL-30853, European urology, 33(2), 1998, pp. 144-151
THE 3-MONTH RECURRENCE AS A PROGNOSTIC FACTOR FOR THE LONG-TERM OUTCOME IN TATL BLADDER-CANCER - RESULTS OF A COMBINED ANALYSIS OF EORTC AND MRC RANDOMIZED TRIALS OF PROPHYLACTIC TREATMENT
Authors: COLLETTE L SYLVESTER RJ DENIS LJ BOUFFIOUX C KURTH K VANDERMEIJDEN AP PARMAR MKB PAWINSKI A
Citation: L. Collette et al., THE 3-MONTH RECURRENCE AS A PROGNOSTIC FACTOR FOR THE LONG-TERM OUTCOME IN TATL BLADDER-CANCER - RESULTS OF A COMBINED ANALYSIS OF EORTC AND MRC RANDOMIZED TRIALS OF PROPHYLACTIC TREATMENT, The Journal of urology, 159(5), 1998, pp. 540-540
URINARY-BLADDER RUPTURE - LAPAROSCOPIC REPAIR
Authors: APPELTANS BMG SCHAPMANS S WILLEMSEN PJA VERBRUGGEN PJEM DENIS LJ
Citation: Bmg. Appeltans et al., URINARY-BLADDER RUPTURE - LAPAROSCOPIC REPAIR, British Journal of Urology, 81(5), 1998, pp. 764-765
A QUALITY-ADJUSTED SURVIVAL (Q-TWIST) ANALYSIS OF EORTC TRIAL-30853 COMPARING MAXIMAL ANDROGEN BLOCKADE (MAB) WITH ORCHIECTOMY IN PATIENTS WITH METASTATIC PROSTATE-CANCER
Authors: ROSENDAHL KI CURRAN D KIEBERT G COLE B WEEKS JC DENIS LJ HALL RR
Citation: Ki. Rosendahl et al., A QUALITY-ADJUSTED SURVIVAL (Q-TWIST) ANALYSIS OF EORTC TRIAL-30853 COMPARING MAXIMAL ANDROGEN BLOCKADE (MAB) WITH ORCHIECTOMY IN PATIENTS WITH METASTATIC PROSTATE-CANCER, European journal of cancer, 33, 1997, pp. 53-53
URINARY-TRACT CANCER - STATE-OF-THE-ART - INTRODUCTION
Authors: DENIS LJ
Citation: Lj. Denis, URINARY-TRACT CANCER - STATE-OF-THE-ART - INTRODUCTION, European urology, 31, 1997, pp. 1-1
MATRIX METALLOPROTEINASE INHIBITORS - PRESENT ACHIEVEMENTS AND FUTURE-PROSPECTS
Authors: DENIS LJ VERWEIJ J
Citation: Lj. Denis et J. Verweij, MATRIX METALLOPROTEINASE INHIBITORS - PRESENT ACHIEVEMENTS AND FUTURE-PROSPECTS, Investigational new drugs, 15(3), 1997, pp. 175-185
HEALTH-CARE RESOURCES SHOULD BE TARGETED TO CHEMOPREVENTION IN PROSTATE-CANCER - THE ARGUMENT FOR
Authors: DENIS LJ
Citation: Lj. Denis, HEALTH-CARE RESOURCES SHOULD BE TARGETED TO CHEMOPREVENTION IN PROSTATE-CANCER - THE ARGUMENT FOR, European urology, 29, 1996, pp. 13-16
CURRENT ISSUES IN PROSTATE-CANCER - A SERIES OF DEBATES - DISCUSSION
Authors: KIRBY RS PAVONEMACALUSO M DENIS LJ GEORGE NJR BOCCONGIBOD L CRAWFORD ED
Citation: Rs. Kirby et al., CURRENT ISSUES IN PROSTATE-CANCER - A SERIES OF DEBATES - DISCUSSION, European urology, 29, 1996, pp. 75-77
COMPARISON OF PHYTOTHERAPY (PERMIXON(R)) WITH FINASTERIDE IN THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA - A RANDOMIZED INTERNATIONAL STUDY OF 1098 PATIENTS
Authors: DENIS LJ
Citation: Lj. Denis, COMPARISON OF PHYTOTHERAPY (PERMIXON(R)) WITH FINASTERIDE IN THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA - A RANDOMIZED INTERNATIONAL STUDY OF 1098 PATIENTS, The Prostate, 29(4), 1996, pp. 241-242
UNTITLED
Authors: DENIS LJ
Citation: Lj. Denis, UNTITLED, The Prostate, 29(3), 1996, pp. 194-194
LASER-INDUCED AUTOFLUORESCENCE DIAGNOSIS OF BLADDER-CANCER - EDITORIAL COMMENT
Authors: DENIS LJ
Citation: Lj. Denis, LASER-INDUCED AUTOFLUORESCENCE DIAGNOSIS OF BLADDER-CANCER - EDITORIAL COMMENT, The Journal of urology, 156(5), 1996, pp. 1601-1601
PROSTATE-CANCER - FOREWORD
Authors: DENIS LJ
Citation: Lj. Denis, PROSTATE-CANCER - FOREWORD, Seminars in surgical oncology, 11(1), 1995, pp. 1-2
HORMONE-REFRACTORY DISEASE
Authors: MAHLER C DENIS LJ
Citation: C. Mahler et Lj. Denis, HORMONE-REFRACTORY DISEASE, Seminars in surgical oncology, 11(1), 1995, pp. 77-83
EUROPEAN-SCHOOL-OF-ONCOLOGY ADVISORY REPORT TO THE EUROPEAN-COMMISSION FOR THE EUROPE AGAINST CANCER PROGRAM EUROPEAN-CODE-AGAINST-CANCER
Authors: BOYLE P VERONESI J TUBIANA M ALEXANDER FE DASILVA FC DENIS LJ FREIRE JM HAKAMA M HIRSCH A KROES R LAVECCHIA C MAISONNEUVE P MARTINMORENO JM NEWTONBISHOP J PINDBORG JJ SARACCI R SCULLY C STANDAERT B STORM H BIANCO S MALBOIS R BLEEHEN N DICATO M PLESNICAR S
Citation: P. Boyle et al., EUROPEAN-SCHOOL-OF-ONCOLOGY ADVISORY REPORT TO THE EUROPEAN-COMMISSION FOR THE EUROPE AGAINST CANCER PROGRAM EUROPEAN-CODE-AGAINST-CANCER, European journal of cancer, 31A(9), 1995, pp. 1395-1405
PROSTATE-CANCER - A CONTINUUM OF CONTROVERSY
Authors: DENIS LJ
Citation: Lj. Denis, PROSTATE-CANCER - A CONTINUUM OF CONTROVERSY, European journal of cancer, 31A(5), 1995, pp. 839-840
PROSTATE-CANCER SCREENING AND PREVENTION - REALITIES AND HOPE
Authors: DENIS LJ
Citation: Lj. Denis, PROSTATE-CANCER SCREENING AND PREVENTION - REALITIES AND HOPE, Urology, 46(3A), 1995, pp. 56-61
EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE-CANCER - PROGRESSREPORT OF ANTWERP AND ROTTERDAM PILOT-STUDIES
Authors: SCHRODER FH DENIS LJ KIRKELS W DEKONING HJ STANDAERT B
Citation: Fh. Schroder et al., EUROPEAN RANDOMIZED STUDY OF SCREENING FOR PROSTATE-CANCER - PROGRESSREPORT OF ANTWERP AND ROTTERDAM PILOT-STUDIES, Cancer, 76(1), 1995, pp. 129-134
REPORT OF THE CONSENSUS WORKSHOP ON SCREENING AND GLOBAL STRATEGY FORPROSTATE-CANCER
Authors: DENIS LJ MURPHY GP SCHODER FH
Citation: Lj. Denis et al., REPORT OF THE CONSENSUS WORKSHOP ON SCREENING AND GLOBAL STRATEGY FORPROSTATE-CANCER, Cancer, 75(5), 1995, pp. 1187-1207
DIAGNOSING BENIGN PROSTATIC HYPERPLASIA VERSUS PROSTATE-CANCER
Authors: DENIS LJ
Citation: Lj. Denis, DIAGNOSING BENIGN PROSTATIC HYPERPLASIA VERSUS PROSTATE-CANCER, British Journal of Urology, 76, 1995, pp. 17-23
HORMONAL-THERAPY OF ADVANCED PROSTATIC-CANCER
Authors: MAHLER C DENIS LJ
Citation: C. Mahler et Lj. Denis, HORMONAL-THERAPY OF ADVANCED PROSTATIC-CANCER, Endocrine-related cancer, 1(4), 1994, pp. 37-52
INDICATIONS FOR HORMONAL TREATMENT
Authors: DENIS LJ
Citation: Lj. Denis, INDICATIONS FOR HORMONAL TREATMENT, Pathologie et biologie, 42(1), 1994, pp. 57-57
3-YEAR SAFETY AND EFFICACY DATA ON THE USE OF FINASTERIDE IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
Authors: STONER E ANDRIOLE GL BOAKE R BRACKEN BR BRANNAN W FUSELIER H BREMNER W BRUSKEWITZ RC COX CE PATTERSON AL CUNNINGHAM GR DEVINE PC SCHELLHAMMER PF ELHILALI M GELLER J GRAYHACK JT HARRISON LH HUDSON PB IMPERATO J VAUGHAN ED LIEBER MM LIPPERT MC MALEK GH MCCONNELL JD NARAYAN P PERREAULT JP RESNICK MI NORMAN R RITTMASTER R ROMAS NA ROSNER W ROSENBLATT S ROY JB SEIDMON EJ TENOVER JS TRACHTENBERG J WILLIAMS RD WALSH PC MOCELLINI A GARDINER R MARSHALL V JOHNSON W BARTSCH G SCHMIDBAUER CP MOSSIG H GASSER G VANCANGH PJ DENIS LJ ARAP S FREIRE GC DELATORRE D BOTTO H RICHARD F DEVONEC M TEILLAC P VALLANCIEN G BRAF Z DISILVERIO F MIANO L PAGANO F GABILONDO F DEBRUYNE F JANKNEGT RA SCHROEDER FH ROLLEMA HJ NACEY J FURTADO LA CARRETERO P JIMENEZ FC HAURI D OTTO R OTTO U ALBRECHT J ALTWEIN JE EGGHART G ENGELMANN U JACOBI GH KREYES G PANIJEL M RIEDASCH G RUGENDORFF EW WEIZERT P FABRICIUS P OBOYLE PJ GINGELL C HEAL MR CHARIG C
Citation: E. Stoner et al., 3-YEAR SAFETY AND EFFICACY DATA ON THE USE OF FINASTERIDE IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA, Urology, 43(3), 1994, pp. 284-294
FINASTERIDE, MSD - INNOVATION IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA - INTRODUCTION
Authors: ALTWEIN JE DENIS LJ
Citation: Je. Altwein et Lj. Denis, FINASTERIDE, MSD - INNOVATION IN THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA - INTRODUCTION, European urology, 25, 1993, pp. 1-2
FUTURE IMPLICATIONS FOR THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA
Authors: DENIS LJ
Citation: Lj. Denis, FUTURE IMPLICATIONS FOR THE MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA, European urology, 25, 1993, pp. 29-34
STAGING AND PROGNOSIS OF PROSTATE-CANCER
Authors: DENIS LJ
Citation: Lj. Denis, STAGING AND PROGNOSIS OF PROSTATE-CANCER, European urology, 24, 1993, pp. 13-18
Risultati: 1-25 | 26-28